相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Global, regional and national burden of primary liver cancer by subtype
Harriet Rumgay et al.
EUROPEAN JOURNAL OF CANCER (2022)
A phase 3 randomized, double-blind, placebo-controlled study of durvalumab in combination with gemcitabine plus cisplatin (GemCis) in patients (pts) with advanced biliary tract cancer (BTC): TOPAZ-1
Do-Youn Oh et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
Maria Reig et al.
JOURNAL OF HEPATOLOGY (2022)
Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma
Philip Johnson et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2022)
Epidemiology of Hepatocellular Carcinoma
Katherine A. McGlynn et al.
HEPATOLOGY (2021)
Surgical Treatments of Hepatobiliary Cancers
Ganesh Gunasekaran et al.
HEPATOLOGY (2021)
Impact of COVID-19 on global HCV elimination efforts
Sarah Blach et al.
JOURNAL OF HEPATOLOGY (2021)
Systemic treatment of hepatocellular carcinoma: An EASL position paper
Jordi Bruix et al.
JOURNAL OF HEPATOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology
Ashish Manne et al.
FRONTIERS IN ONCOLOGY (2021)
Comparison of liver cancer incidence and survival by subtypes across seven high-income countries
Mark J. Rutherford et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Next-Generation Biomarkers for Cholangiocarcinoma
Pedro M. Rodrigues et al.
CANCERS (2021)
Ampullary Carcinoma: An Overview of a Rare Entity and Discussion of Current and Future Therapeutic Challenges
Alessandro Rizzo et al.
CURRENT ONCOLOGY (2021)
Klatskin Tumor in the Light of ICD-O-3: A Population-Based Clinical Outcome Study Involving 1,144 Patients from the Surveillance, Epidemiology, and End Result (SEER) Database (2001-2012)
Jaffar Khan et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2021)
Long-Term Risk of Hepatocellular Carcinoma in HCV Patients Treated With Direct Acting Antiviral Agents
Fasiha Kanwal et al.
HEPATOLOGY (2020)
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis
Oliver Clements et al.
JOURNAL OF HEPATOLOGY (2020)
Attributable Fractions of Nonalcoholic Fatty Liver Disease for Mortality in the United States: Results From the Third National Health and Nutrition Examination Survey With 27 Years of Follow-up
Christian S. Alvarez et al.
HEPATOLOGY (2020)
International trends in hepatocellular carcinoma incidence, 1978-2012
Jessica L. Petrick et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Geographical and Temporal Variation in the Incidence and Mortality of Hepato-Pancreato-Biliary Primary Malignancies:1990-2017
Andrew J. Weaver et al.
JOURNAL OF SURGICAL RESEARCH (2020)
EASL recommendations on treatment of hepatitis C: Final update of the series
Jean-Michel Pawlotsky et al.
JOURNAL OF HEPATOLOGY (2020)
Atezolizumab and Bevacizumab in Hepatocellular Carcinoma
David Bomze et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
From NASH to HCC: current concepts and future challenges
Quentin M. Anstee et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Projections of primary liver cancer to 2030 in 30 countries worldwide
Patricia C. Valery et al.
HEPATOLOGY (2018)
AASLD guidelines for the treatment of hepatocellular carcinoma
Julie K. Heimbach et al.
HEPATOLOGY (2018)
Poor adherence to hepatocellular carcinoma surveillance: A systematic review and meta-analysis of a complex issue
Changqing Zhao et al.
LIVER INTERNATIONAL (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
G. K. Abou-Alfa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Disease burden of hepatitis C in the Austrian state of Tyrol - Epidemiological data and model analysis to achieve elimination by 2030
Benedikt Schaefer et al.
PLOS ONE (2018)
Review article: systemic treatment of hepatocellular carcinoma
Matthias Pinter et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
Fasiha Kanwal et al.
GASTROENTEROLOGY (2018)
Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study
Ian Chau et al.
EUROPEAN JOURNAL OF CANCER (2017)
Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression
Reem Waziry et al.
JOURNAL OF HEPATOLOGY (2017)
Global trends and predictions in hepatocellular carcinoma mortality
Paola Bertuccio et al.
JOURNAL OF HEPATOLOGY (2017)
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Jordi Bruix et al.
LANCET (2017)
Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
J. W. Valle et al.
ANNALS OF ONCOLOGY (2016)
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
Jesus M. Banales et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Forty-Year Trends in Cholangiocarcinoma Incidence in the US: Intrahepatic Disease on the Rise
Supriya K. Saha et al.
ONCOLOGIST (2016)
Epidemiological Trends of Hepatocellular Carcinoma in Austria
Matthias Pinter et al.
DIGESTIVE DISEASES (2014)
Incidence and mortality trends for biliary tract cancers in Austria
Matthias Pinter et al.
LIVER INTERNATIONAL (2014)
Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis
Amit G. Singal et al.
PLOS MEDICINE (2014)
Molecular Gene Expression Profiling to Predict the Tissue of Origin and Direct Site-Specific Therapy in Patients With Carcinoma of Unknown Primary Site: A Prospective Trial of the Sarah Cannon Research Institute
John D. Hainsworth et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Rising trends in cholangiocarcinoma: Is the ICD classification system misleading us?
Shahid A. Khan et al.
JOURNAL OF HEPATOLOGY (2012)
Clinical characteristics of patients with hepatocellular carcinoma in Austria - is there a need for a structured screening program?
Florian Hucke et al.
WIENER KLINISCHE WOCHENSCHRIFT (2011)
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer.
Juan Valle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Gallstones and the risk of biliary tract cancer: a population-based study in China
A. W. Hsing et al.
BRITISH JOURNAL OF CANCER (2007)